Takeda Pharmaceutical Company Limited (BVMF:TAKP34)

BVMF:TAKP34 Revenue

Takeda Pharmaceutical Company had revenue of 1.11T JPY in the quarter ending September 30, 2025, a decrease of -5.38%. This brings the company's revenue in the last twelve months to 4.42T, down -2.84% year-over-year. In the fiscal year ending March 31, 2025, Takeda Pharmaceutical Company had annual revenue of 4.58T with 7.45% growth.

• Revenue (ttm): 4.42T JPY
• Revenue Growth: -2.84%
• P/S Ratio: 1.49
• Revenue / Employee: 93.08M JPY
• Employees: 47,455
• Market Cap: 236.76B BRL

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	4.58T	317.79B	7.45%
Mar 31, 2024	4.26T	236.28B	5.87%
Mar 31, 2023	4.03T	458.47B	12.85%
Mar 31, 2022	3.57T	371.19B	11.61%
Mar 31, 2021	3.20T	-93.38B	-2.84%